Literature DB >> 29353250

Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication.

Heike Bantel1, Ali Canbay2.   

Abstract

Entities:  

Keywords:  apoptosis; carcinogenesis; liver

Mesh：

Substances：

Year:  2018        PMID： 29353250     DOI： 10.1136/gutjnl-2017-315630

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11.

Authors:  Anne Gaza; Valerie Fritz; Lara Malek; Laura Wormser; Nora Treiber; Johannes Danner; Andreas E Kremer; Wolfgang E Thasler; Jürgen Siebler; Gunter Meister; Markus F Neurath; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Neoplasia       Date:  2021-04-24       Impact factor: 5.715

2.  miR-622 Counteracts the NUAK1-Induced Gastric Cancer Cell Proliferation and the Antioxidative Stress.

Authors:  Jian Yang; Jian Lu; Ni Yin; Jingyue Sun; Jianhong Pu; Jin Zang
Journal:  Dis Markers       Date:  2022-07-14       Impact factor: 3.464

3.  Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line.

Authors:  Muhammad Atif; Muhammad Abdul Mustaan; Sadia Falak; Abdul Ghaffar; Bushra Munir
Journal:  Saudi J Biol Sci       Date:  2022-06-01       Impact factor: 4.052

Review 4.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.